HSN 003839
Alternative Names: HSN-003839Latest Information Update: 18 Jul 2024
At a glance
- Originator Chongqing Pharscin Pharmaceutical
- Class Antineoplastics
- Mechanism of Action USP21 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer